loadpatents
name:-0.0098879337310791
name:-0.014739036560059
name:-0.0034031867980957
Binch; Hayley Marie Patent Filings

Binch; Hayley Marie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Binch; Hayley Marie.The latest application filed is for "modulators of cystic fibrosis transmembrane conductance regulator".

Company Profile
3.16.15
  • Binch; Hayley Marie - Encinitas CA
  • Binch; Hayley Marie - Boston MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 11,426,407 - Miller , et al. August 30, 2
2022-08-30
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20210052584 - Miller; Mark Thomas ;   et al.
2021-02-25
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,758,534 - Miller , et al. Sep
2020-09-01
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,258,624 - Miller , et al.
2019-04-16
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20180185364 - Miller; Mark Thomas ;   et al.
2018-07-05
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 9,782,408 - Miller , et al. October 10, 2
2017-10-10
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20170196862 - Miller; Mark Thomas ;   et al.
2017-07-13
Compounds useful as inhibitors of ATR kinase
Grant 9,630,956 - Charrier , et al. April 25, 2
2017-04-25
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
App 20160095858 - Miller; Mark Thomas ;   et al.
2016-04-07
Pharmaceutical Compositions and Administrations Thereof
App 20160022665 - Van Goor; Fredrick F. ;   et al.
2016-01-28
Pharmaceutical Compositions and Administrations Thereof
App 20160022664 - Van Goor; Fredrick F. ;   et al.
2016-01-28
Morpholine-spirocyclic piperidine amides as modulators of ion channels
Grant 9,181,273 - Hadida-Ruah , et al. November 10, 2
2015-11-10
Pharmaceutical Compositions and Administrations Thereof
App 20150164881 - Van Goor; Fredrick F. ;   et al.
2015-06-18
Pharmaceutical Compositions And Administrations Thereof
App 20150164883 - Van Goor; Fredrick F. ;   et al.
2015-06-18
Morpholine-spirocyclic Piperidine Amides As Modulators Of Ion Channels
App 20150025073 - Hadida-Ruah; Sara Sabina ;   et al.
2015-01-22
Morpholine-spirocyclic piperidine amides as modulators of ion channels
Grant 8,828,996 - Hadida-Ruah , et al. September 9, 2
2014-09-09
Triazole compounds useful as protein kinase inhibitors
Grant 8,633,210 - Charrier , et al. January 21, 2
2014-01-21
Pharmaceutical Compositions And Administrations Thereof
App 20130158071 - Van Goor; Fredrick F. ;   et al.
2013-06-20
Pharmaceutical Compositions And Administrations Thereof
App 20130131107 - Van Goor; Fredrick F. ;   et al.
2013-05-23
Compounds useful as inhibitors of ATR kinase
Grant 8,410,112 - Charrier , et al. April 2, 2
2013-04-02
Morpholine-spirocyclic Piperidine Amides As Modulators Of Ion Channels
App 20120264749 - Hadida-Ruah; Sara Sabina ;   et al.
2012-10-18
Caspase inhibitors and uses thereof
Grant 8,288,537 - Golec , et al. October 16, 2
2012-10-16
Compounds Useful As Inhibitors Of Atr Kinase
App 20120027874 - Charrier; Jean-Damien ;   et al.
2012-02-02
Caspase inhibitors and uses thereof
Grant 8,093,392 - Golec , et al. January 10, 2
2012-01-10
Drug Discovery Methods
App 20110269732 - GOLEC; Julian M.C. ;   et al.
2011-11-03
Caspase inhibitors and uses thereof
Grant 7,906,650 - Golec , et al. March 15, 2
2011-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed